[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100607054":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":13,"locations":7,"responsibleParty":19,"collaborators":7,"id":23,"slug":24,"hasResults":25,"nctId":26,"briefTitle":27,"officialTitle":28,"acronym":7,"eligibilityCriteria":29,"healthyVolunteers":25,"sex":30,"minAge":31,"maxAge":7,"enrollmentInfo":32,"targetDuration":7,"studyType":35,"phases":7,"briefSummary":36,"conditions":37,"keywords":7,"overallStatus":40,"whyStopped":7,"lastUpdateSubmitDate":41,"lastUpdatePostDateStruct":42,"startDateStruct":45,"completionDateStruct":47,"leadSponsor":49,"locationsCount":7},{"fullName":5,"class":6},"Assiut University","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DEVICE","Ct","Ct volume measurement of HCC after TACE or MWA",[14],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Ahmes Saber Hamed, Master","CONTACT","+2001019545804","Ahmed.17289721@med.aun.edu.eg",{"type":20,"investigatorFullName":21,"investigatorTitle":22,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Ahmed Saber Hamed Ahmed","Assistant lecturer","100607054","ct-volume-measurement-of-hepatocellular-carcinoma-100607054",false,"NCT07183566","CT Volume Measurement of Hepatocellular Carcinoma","Ct Volume Measurement of Hepatocellular Carcinoma After Transarterial Chemoembolization (TACE) or Microwave Ablation (MWA)","Inclusion Criteria:\n\n* Adult patients (≥18 years) with a confirmed diagnosis of HCC based on AASLD or EASL criteria.\n* Patients deemed unresectable by the multidisciplinary tumor board.\n* Patients scheduled for TACE as the primary locoregional therapy.\n* Preserved liver function (Child-Pugh class A or B).\n* Adequate renal function to permit contrast-enhanced CT.\n\nExclusion Criteria:\n\n* Patients with extrahepatic metastases or portal vein thrombosis.\n* Patients with contraindications to iodinated contrast or TACE.\n* Patients with severe comorbid illness that precludes participation.\n* Patients refuse to provide informed consent.","ALL","18 Years",{"count":33,"type":34},66,"ESTIMATED","OBSERVATIONAL","The aim of this study is to evaluate the role of CT volumetric measurement in assessing treatment response of hepatocellular carcinoma (HCC) following trans arterial chemoembolization (TACE) or microwave ablation (MWA)",[38,39],"Hepatocellular Carcinoma (HCC)","CT","NOT_YET_RECRUITING","2025-09-17",{"date":43,"type":44},"2025-09-19","ACTUAL",{"date":46,"type":34},"2025-10-01",{"date":48,"type":34},"2027-11-01",{"name":5,"class":6}]